Chemical Compound

Aclucinomycin A

CAS Registry Number 79617-46-2
Aclucinomycin A chemical structure
Primary Record

Aclucinomycin A

In stock
9,972 g
Purity
99.8 %
CAS
79617-46-2

Compound Identifiers & Properties

CAS
79617-46-2
PubChem CID
308141
SMILES
CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O
Canonical SMILES
CC[C@@]1(O)C[C@H](OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC

Names & Synonyms

  • Aclucinomycin A
  • aclarubicin
  • Aclacinomycin A
  • Aclacinomycin
  • Aclarubicinum
  • Aclarubicine
  • Aclarubicino
  • Aclacin
  • Aclacur
  • Antibiotic MA 144A
  • Antibiotic MA 144A1
  • Antibiotic MA144-A1
  • AC1L7CAE
  • Aclarubicine [INN-French]
  • Aclarubicinum [INN-Latin]
  • Aclarubicino [INN-Spanish]
  • CHEMBL45414
  • DivK1c_000678
  • UNII-74KXF8I502
  • Aclarubicin [USAN:BAN:INN]
  • Aclarubicin [USAN:INN:BAN]
  • CCRIS 2262
  • SCHEMBL1649619
  • SCHEMBL31238004
  • HMS502B20
  • KBio1_000678
  • MA 144-A1
  • NINDS_000678
  • NSC208734
  • NSC 208734
  • NSC-208734
  • EINECS 260-824-3
  • CID308141
  • NSC240619
  • C42-H53-N-O15
  • NSC-240619
  • IDI1_000678
  • QTL1_000003
  • NCI60_001746
  • PD011255
  • 79617-46-2
  • methyl (1R,2R,4S)-4-[4-(dimethylamino)-5-[4-hydroxy-6-methyl-5-(6-methyl-5-oxooxan-2-yl)oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
  • 57576-44-0
  • 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-.alpha.-L-lyxo-hexopyranosyl]-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, methyl ester, radical ion(1-), (1R-(1.alpha.,2.beta.,4.beta.))-
  • 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-.alpha.-L-lyxo-hexopyranosyl]-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, methyl ester, [1R-(1.alpha.,2.beta.,4.beta.)]-
  • 1-Naphthacenecarboxylic acid,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-.alpha.-L-lyxo-hexopyranosyl]-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, methyl ester, radical ion(1-), (1R-(1.alpha.,2.beta.,4.beta.))-
  • 1-Naphthacenecarboxylic acid,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-.alpha.-L-lyxo-hexopyranosyl]-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, methyl ester,(1R-(1.alpha.,2.beta.,4.beta.))-
  • Methyl (1R,2R,4S)-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-1-naphthacenecarboxylate